Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 105

Similar articles for PubMed (Select 21881130)

1.

IL-10 neutralization promotes parasite clearance in splenic aspirate cells from patients with visceral leishmaniasis.

Gautam S, Kumar R, Maurya R, Nylén S, Ansari N, Rai M, Sundar S, Sacks D.

J Infect Dis. 2011 Oct 1;204(7):1134-7. doi: 10.1093/infdis/jir461.

2.

Splenic accumulation of IL-10 mRNA in T cells distinct from CD4+CD25+ (Foxp3) regulatory T cells in human visceral leishmaniasis.

Nylén S, Maurya R, Eidsmo L, Manandhar KD, Sundar S, Sacks D.

J Exp Med. 2007 Apr 16;204(4):805-17. Epub 2007 Mar 26.

3.

Neutralization of IL-12 demonstrates the existence of discrete organ-specific phases in the control of Leishmania donovani.

Engwerda CR, Murphy ML, Cotterell SE, Smelt SC, Kaye PM.

Eur J Immunol. 1998 Feb;28(2):669-80.

PMID:
9521077
4.

Leishmania donovani: dynamics of L. donovani evasion of innate immune cell attack due to malnutrition in visceral leishmaniasis.

Kumar V, Bimal S, Singh SK, Chaudhary R, Das S, Lal C, Pandey K, Das VR, Das P.

Nutrition. 2014 Apr;30(4):449-58. doi: 10.1016/j.nut.2013.10.003. Epub 2013 Oct 14.

PMID:
24607302
5.
6.

Leishmania donovani: immunostimulatory cellular responses of membrane and soluble protein fractions of splenic amastigotes in cured patient and hamsters.

Kumari S, Misra P, Tandon R, Samant M, Sundar S, Dube A.

PLoS One. 2012;7(1):e30746. doi: 10.1371/journal.pone.0030746. Epub 2012 Jan 26.

7.

TLR-mediated distinct IFN-γ/IL-10 pattern induces protective immunity against murine visceral leishmaniasis.

Paul J, Karmakar S, De T.

Eur J Immunol. 2012 Aug;42(8):2087-99. doi: 10.1002/eji.201242428.

PMID:
22622993
8.

Interleukin-10 and the pathogenesis of human visceral leishmaniasis.

Nylén S, Sacks D.

Trends Immunol. 2007 Sep;28(9):378-84. Epub 2007 Aug 6. Review.

PMID:
17689290
9.
10.

Reassessment of immune correlates in human visceral leishmaniasis as defined by cytokine release in whole blood.

Singh OP, Gidwani K, Kumar R, Nylén S, Jones SL, Boelaert M, Sacks D, Sundar S.

Clin Vaccine Immunol. 2012 Jun;19(6):961-6. doi: 10.1128/CVI.00143-12. Epub 2012 Apr 25.

11.

IL-12 enhances Th1-type responses in human Leishmania donovani infections.

Ghalib HW, Whittle JA, Kubin M, Hashim FA, el-Hassan AM, Grabstein KH, Trinchieri G, Reed SG.

J Immunol. 1995 May 1;154(9):4623-9.

PMID:
7722314
12.

Evaluation of Leishmania donovani disulfide isomerase as a potential target of cellular immunity against visceral leishmaniasis.

Amit A, Chaudhary R, Yadav A, Suman SS, Narayan S, Das VN, Pandey K, Singh SK, Singh BK, Ali V, Das P, Bimal S.

Cell Immunol. 2014 May-Jun;289(1-2):76-85. doi: 10.1016/j.cellimm.2014.03.011. Epub 2014 Apr 3.

PMID:
24732062
13.
14.

115 kDa serine protease confers sustained protection to visceral leishmaniasis caused by Leishmania donovani via IFN-γ induced down-regulation of TNF-α mediated MMP-9 activity.

Choudhury R, Das P, De T, Chakraborti T.

Immunobiology. 2013 Jan;218(1):114-26. doi: 10.1016/j.imbio.2012.02.008. Epub 2012 Feb 16.

PMID:
22440312
17.

The IL-33/ST2 axis is associated with human visceral leishmaniasis and suppresses Th1 responses in the livers of BALB/c mice infected with Leishmania donovani.

Rostan O, Gangneux JP, Piquet-Pellorce C, Manuel C, McKenzie AN, Guiguen C, Samson M, Robert-Gangneux F.

MBio. 2013 Sep 17;4(5):e00383-13. doi: 10.1128/mBio.00383-13.

18.
19.

Prophylactic efficacy of high-molecular-weight antigenic fractions of a recent clinical isolate of Leishmania donovani against visceral leishmaniasis.

Tripathi P, Gupta SK, Sinha S, Sundar S, Dube A, Naik S.

Scand J Immunol. 2008 Nov;68(5):492-501. doi: 10.1111/j.1365-3083.2008.02171.x. Epub 2008 Sep 18.

PMID:
18803606
20.

The capacity to produce IFN-gamma rather than the presence of interleukin-4 determines the resistance and the degree of susceptibility to Leishmania donovani infection in mice.

Lehmann J, Enssle KH, Lehmann I, Emmendörfer A, Lohmann-Matthes ML.

J Interferon Cytokine Res. 2000 Jan;20(1):63-77.

PMID:
10670653
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk